PAPER Bardai FH, Verma P, Smith C, Rawat V, Wang L, D'Mello SR
SEARCH RESULTS
329967 RESULTS
PAPER Schafer KN, Cisek K, Huseby CJ, Chang E, Kuret J
Structural Determinants of Tau Aggregation Inhibitor Potency.
J Biol Chem. 2013 Nov 8;288(45):32599-611. PubMed: 24072703PAPER Mancuso R, Baglio F, Cabinio M, Calabrese E, Hernis A, Nemni R, Clerici M
Titers of Herpes Simplex Virus Type 1 Antibodies Positively Correlate with Grey Matter Volumes in Alzheimer's Disease.
J Alzheimers Dis. 2013 Sep 26; PubMed: 24072067PAPER Cholerton B, Baker LD, Craft S
Insulin, cognition, and dementia.
Eur J Pharmacol. 2013 Nov 5;719(1-3):170-9. PubMed: 24070815PAPER Odenheimer G, Borson S, Sanders AE, Swain-Eng RJ, Kyomen HH, Tierney S, Gitlin LN, Forciea MA, Absher J, Shega J, Johnson J
Quality improvement in neurology: Dementia management quality measures.
Neurology. 2013 Oct 22;81(17):1545-1549. PubMed: 24068786PAPER Larson EB
The body-mind connection in aging and dementia.
J Am Geriatr Soc. 2013 Jul;61(7):1210-1. PubMed: 23855848PAPER Koleske AJ
Molecular mechanisms of dendrite stability.
Nat Rev Neurosci. 2013 Aug;14(8):536-50. PubMed: 23839597PAPER Kim KS, Lee HJ, An J, Kim YB, Ra JC, Lim I, Kim SU
Transplantation of human adipose tissue-derived stem cells delays clinical onset and prolongs life span in ALS mouse model.
Cell Transplant. 2013 Sep 18; PubMed: 24070071PAPER Krasnoslobodtsev AV, Volkov IL, Asiago JM, Hindupur J, Rochet JC, Lyubchenko YL
Alpha-synuclein misfolding assessed with single molecule AFM force spectroscopy: Effect of pathogenic mutations.
Biochemistry. 2013 Oct 22;52(42):7377-86. PubMed: 24066883PAPER Pham CL, Cappai R
The interplay between lipids and dopamine on α-synuclein oligomerisation and membrane binding.
Biosci Rep. 2013 Sep 25; PubMed: 24066973PAPER Hosokawa M, Arai T, Yamashita M, Tsuji H, Nonaka T, Masuda-Suzukake M, Tamaoka A, Hasegawa M, Akiyama H
Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.
Int J Neurosci. 2013 Oct 31; PubMed: 24066851PAPER Novakovic D, Feligioni M, Scaccianoce S, Caruso A, Piccinin S, Schepisi C, Errico F, Mercuri NB, Nicoletti F, Nisticò R
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease.
Drug Des Devel Ther. 2013;7:1359-64. Epub 2013 Nov 13 PubMed: 24255592PAPER Plantin LO, Lying-Tunell U, Kristensson K
Trace elements in the human central nervous system studied with neutron activation analysis.
Biol Trace Elem Res. 1987 Aug;13(1):69-75. PubMed: 24254666PAPER Krishnan SS, Harrison JE, McLachlan DR
Origin and resolution of the aluminum controversy concerning Alzheimer's neurofibrillary degeneration.
Biol Trace Elem Res. 1987 Aug;13(1):35-42. PubMed: 24254663PAPER Ehmann WD, Markesbery WR, Kasarskis EJ, Vance DE, Khare SS, Hord JD, Thompson CM
Applications of neutron activation analysis to the study of age-related neurological diseases.
Biol Trace Elem Res. 1987 Aug;13(1):19-33. PubMed: 24254662Current Filters
No filters selected